Additional exercise therapy in patients with peripheral arterial disease: The value of supervised exercise therapy after invasive treatment of peripheral arterial disease.

Completed

• Conditions: 10003216; intermittent claudication; Peripheral arterial disease

• Registration Number: NL-OMON30240
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

Patients with peripheral arterial disease, fontaine stadium 2, 3, or 4, with an indication for angioplasty or surgical reconstruction

Exclusion Criteria

Disability to exercise as a result of peripheral arterial disease, serieus cardiac or pulmonary comorbidity (NYHA 3 and 4), other comorbidities that disable exercise therapy and inadequate knowledge of the Dutch language

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome is the absolute claudication distance in meters. This is<br /><br>the distance at which a patient can not walk any further, and is determined by<br /><br>a standard treadmill protocol.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Additional outcomes are initial claudication distance, quality of life,<br /><br>fontaine stadium, ankle brachial index, vascular risk factors,<br /><br>re-interventions, number of attended sessions, patency and mortality. </p><br>